| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,572 | 38,475 | 37,371 | 37,217 | | Cost of Revenue | 31,025 | 18,763 | 24,072 | 21,935 | | | Gross Profit | 8,547 | 19,712 | 13,299 | 15,282 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (2,445) | 4,878 | 4,420 | 7,025 | | Non Recurring | 28,575 |
-
|
-
|
-
| | Others | 7,275 | 7,494 | 7,308 | 7,918 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,717 | 7,340 | 1,571 | 339 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24,489) | (20,737) | 3,912 | (72,713) | | Earnings Before Interest And Taxes | (49,400) | (13,697) | 5,483 | (75,497) | | Interest Expense | (35,116) | 18,487 | 16,629 | (51,639) | | Income Before Tax | (14,284) | (32,184) | (11,146) | (23,858) | | Income Tax Expense | (956) | (51) | 110 | (3,316) | | Minority Interest | 136 |
-
|
-
| 654 | | | | Net Income From Continuing Ops | (13,328) | (32,133) | (11,256) | (20,542) | | | Non-recurring Events | | Discontinued Operations | 2,097 | 95 | 388 | 6,320 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,095) | (32,038) | (10,868) | (14,222) | | Preferred Stock And Other Adjustments | (452) | (163) | (141) | (257) | | | Net Income Applicable To Common Shares | ($11,547) | ($32,201) | ($11,009) | ($14,479) |
|
0.11% Nasdaq 0.00%
Income Statement
